Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Green

Neurology

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Neurology|December 11, 2012
Fingolimod treatment in multiple sclerosis leads to increased macular volumeRachel Nolan, Jeffrey M Gelfand, Ari J Green
Neurology|September 1, 1984
Interpretation of serum phenytoin concentrations in uremia is assay-dependentM A Sirgo, P J Green, M L Rocci, et al.
Neurology|July 1, 1997
Tactile spatial acuity and roughness discrimination: impairments due to aging and Parkinson's diseaseK Sathian, A Zangaladze, J Green, et al.
Neurology|March 1, 1990
Progressive aphasia: a precursor of global dementia?J Green, J C Morris, J Sandson, et al.
Neurology|January 1, 1997
Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathyA M Connolly, A Pestronk, S Mehta, et al.
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
Neurology|November 13, 2002
Cognitive impairments in advanced PD without dementiaJ Green, W M McDonald, J L Vitek, et al.
Neurology|November 4, 2000
Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindredS J Pittock, C Joyce, V O'Keane, et al.
Neurology|March 27, 2002
Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findingsJ Green, W M McDonald, J L Vitek, et al.
Neurology|May 3, 2014
Retinal architecture and mfERG: Optic nerve head component response characteristics in MSZane S Schnurman, Teresa C Frohman, Shin C Beh, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neurology|December 11, 2012
Fingolimod treatment in multiple sclerosis leads to increased macular volumeRachel Nolan, Jeffrey M Gelfand, Ari J Green
Neurology|September 1, 1984
Interpretation of serum phenytoin concentrations in uremia is assay-dependentM A Sirgo, P J Green, M L Rocci, et al.
Neurology|July 1, 1997
Tactile spatial acuity and roughness discrimination: impairments due to aging and Parkinson's diseaseK Sathian, A Zangaladze, J Green, et al.
Neurology|March 1, 1990
Progressive aphasia: a precursor of global dementia?J Green, J C Morris, J Sandson, et al.
Neurology|January 1, 1997
Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathyA M Connolly, A Pestronk, S Mehta, et al.
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
Neurology|November 13, 2002
Cognitive impairments in advanced PD without dementiaJ Green, W M McDonald, J L Vitek, et al.
Neurology|November 4, 2000
Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindredS J Pittock, C Joyce, V O'Keane, et al.
Neurology|March 27, 2002
Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findingsJ Green, W M McDonald, J L Vitek, et al.
Neurology|May 3, 2014
Retinal architecture and mfERG: Optic nerve head component response characteristics in MSZane S Schnurman, Teresa C Frohman, Shin C Beh, et al.
Pageof 2